Experion Holdings Ltd.

publicPublic Group

Experion Holdings Ltd. (formerly Viridium Pacific Group Ltd). is a Canadian public capital company trading on the Toronto Venture Exchange (TSXV: EXP). We specialize in investing in the Canadian cannabis industry.

people26 Members       (0)

Corporate Profile
Group Admins:
  • Thumb 8020 monitor 200 200  png
  • Thumb 20190424 083700 film4 1
Join Group


Experion Holdings Ltd.

publicPublicGroup

Experion Holdings Ltd. (formerly Viridium Pacific Group Ltd). is a Canadian public capital company trading on the Tor......

people26 Members       (0)


German medical cannabis market led by older patients; 750 kilograms of flower imported in Q1


German medical cannabis market led by older patients; 750 kilograms of flower imported in Q1

info This topic contains 0 replies, has 0 voice
Viewing 1 post (of 1 total)

Author
Post
Favourite turned_in
 
access_time

Thumb 20190424 083700 film4 1
JUDY-ANN POTTINGER
Moderator

Dear Investor,


I would like to share an article, excerpt and link below, that speaks to the German medical cannabis market.  The German marketplace described as a ‘’linchpin for many international marijuana companies’’ is an important one for Viridium and in fact, Viridium has already secured entry into the German medical cannabis market.


More than 750 kilograms of medical cannabis flower was imported to Germany in the first quarter of this year, putting the country on pace to import about the same amount in 2019 as it did last year – 3,000 kilograms.


This is according to new data from the government, providing clarity on the actual size of a market that is a linchpin for many international marijuana companies.


https://mjbizdaily.com/german-medical-cannabis-market-led-by-older-patients-750-kg-flower-imported-q1/


Viridium announced on December 27, 2018, that the Company had signed an agreement with INOPHA GmbH a pharmaceutical distributor for the German market to enter the tender process within Germany and acquire a license to cultivate medical cannabis – the link below.


Chief Executive Officer, Jay Garnett, commented: “The German medical cannabis patient relies on high-quality cannabis supply that meets the rigorous standards of regulations, such as those governing our industry in Canada. INOPHA’s interest in working with a Canadian LP, such as Viridium, stems from the need to partner with a proven operator with a track record of supplying the medical market.” Mr. Garnett further stated, “We look forward to working with INOPHA to build a quality medical cannabis producer in Germany.”


https://www.viridiumpacific.com/viridium-signs-agreement-with-german-partner-inopha-entering-the-tender-process-to-cultivate-medical-cannabis-in-germany/


Viridium continues to execute on its business plan, a key and seminal move by Viridium has been to secure the requisite licenses and seek out partnerships that will greatly enhance the Company’s growth domestically and internationally.


Thank you for reading.  Stay Tuned!!!!

access_time

Thumb 20190424 083700 film4 1
JUDY-ANN POTTINGER
Moderator

Dear Investor,

I would like to share an article, excerpt and link below, that speaks to the German medical cannabis market.  The German marketplace described as a ‘’linchpin for many international marijuana companies’’ is an important one for Viridium and in fact, Viridium has already secured entry into the German medical cannabis market.

More than 750 kilograms of medical cannabis flower was imported to Germany in the first quarter of this year, putting the country on pace to import about the same amount in 2019 as it did last year – 3,000 kilograms.

This is according to new data from the government, providing clarity on the actual size of a market that is a linchpin for many international marijuana companies.

https://mjbizdaily.com/german-medical-cannabis-market-led-by-older-patients-750-kg-flower-imported-q1/

Viridium announced on December 27, 2018, that the Company had signed an agreement with INOPHA GmbH a pharmaceutical distributor for the German market to enter the tender process within Germany and acquire a license to cultivate medical cannabis – the link below.

Chief Executive Officer, Jay Garnett, commented: “The German medical cannabis patient relies on high-quality cannabis supply that meets the rigorous standards of regulations, such as those governing our industry in Canada. INOPHA’s interest in working with a Canadian LP, such as Viridium, stems from the need to partner with a proven operator with a track record of supplying the medical market.” Mr. Garnett further stated, “We look forward to working with INOPHA to build a quality medical cannabis producer in Germany.”

https://www.viridiumpacific.com/viridium-signs-agreement-with-german-partner-inopha-entering-the-tender-process-to-cultivate-medical-cannabis-in-germany/

Viridium continues to execute on its business plan, a key and seminal move by Viridium has been to secure the requisite licenses and seek out partnerships that will greatly enhance the Company’s growth domestically and internationally.

Thank you for reading.  Stay Tuned!!!!


Viewing 1 post (of 1 total)